Understanding The Potential Drug Target Status of KCNAB1 (G7881)

Target Name: KCNAB1

NCBI ID: G7881

KCNAB1

Understanding The Potential Drug Target Status of KCNAB1

KCNAB1, also known as Voltage-gated potassium channel subunit beta-1 (isoform 1), is a protein that plays a crucial role in the function of the nervous system. It is a subunit of the voltage-gated potassium channel, which is responsible for allowing the movement of electrical signals in and out of cells. In this article, we will discuss the potential drug target status of KCNAB1 and its potential impact on the treatment of various neurological disorders.

Chemical Background

KCNAB1 is a protein that consists of 126 amino acids. It is a voltage-gated potassium channel subunit that is expressed in many different tissues, including muscle, heart, brain, and sensory neurons. The function of KCNAB1 is to regulate the flow of electrical signals in and out of cells.

Drug Target Status

KCNAB1 has been identified as a potential drug target for a variety of neurological disorders. Its role in the regulation of electrical signals has led to its potential as a therapeutic agent for a range of disorders that involve the transmission of electrical signals in the nervous system.

One of the main reasons for the potential drug target status of KCNAB1 is its involvement in the regulation of action potentials. Action potentials are the electrical signals that are generated by the rapid influx of calcium ions into the neuron. These signals are responsible for the transmission of information and are essential for the functioning of the nervous system.

Studies have shown that KCNAB1 plays a role in the regulation of action potentials by allowing the movement of electrical signals in and out of cells. This protein helps to regulate the amount of calcium ions that enter the neuron, which is critical for the generation of action potentials.

In addition to its role in the regulation of action potentials, KCNAB1 has also been shown to play a role in the regulation of neuronal excitability. This protein helps to regulate the release of neurotransmitters, which are chemicals that are responsible for transmitting signals between neurons.

Potential Therapeutic Applications

The potential drug target status of KCNAB1 makes it an attractive target for the treatment of a variety of neurological disorders. Some of the potential therapeutic applications of this protein include:

1. epilepsy: KCNAB1 has been shown to play a role in the regulation of epilepsy, a common and often debilitating neurological disorder. Studies have shown that inhibiting the function of KCNAB1 may be an effective way to treat epilepsy.
2. chronic pain: KCNAB1 has also been shown to play a role in the regulation of pain. Studies have shown that inhibiting the function of this protein may be an effective way to treat chronic pain.
3. neurodegenerative disorders: KCNAB1 has been shown to play a role in the regulation of the transmission of electrical signals in the brain, which is critical for the functioning of neurons. Therefore, inhibiting the function of this protein may be an effective way to treat neurodegenerative disorders.

Conclusion

In conclusion, KCNAB1 is a protein that plays a crucial role in the function of the nervous system. Its potential drug target status makes it an attractive target for the treatment of a variety of neurological disorders. Further research is needed to fully understand the role of this protein in the regulation of electrical signals in the nervous system.

Protein Name: Potassium Voltage-gated Channel Subfamily A Regulatory Beta Subunit 1

Functions: Cytoplasmic potassium channel subunit that modulates the characteristics of the channel-forming alpha-subunits (PubMed:7499366, PubMed:7603988, PubMed:17156368, PubMed:17540341, PubMed:19713757). Modulates action potentials via its effect on the pore-forming alpha subunits (By similarity). Promotes expression of the pore-forming alpha subunits at the cell membrane, and thereby increases channel activity (By similarity). Mediates closure of delayed rectifier potassium channels by physically obstructing the pore via its N-terminal domain and increases the speed of channel closure for other family members (PubMed:9763623). Promotes the closure of KCNA1, KCNA2 and KCNA5 channels (PubMed:7499366, PubMed:7890032, PubMed:7603988, PubMed:7649300, PubMed:8938711, PubMed:12077175, PubMed:12130714, PubMed:15361858, PubMed:17540341, PubMed:19713757). Accelerates KCNA4 channel closure (PubMed:7890032, PubMed:7649300, PubMed:7890764, PubMed:9763623). Accelerates the closure of heteromeric channels formed by KCNA1 and KCNA4 (PubMed:17156368). Accelerates the closure of heteromeric channels formed by KCNA2, KCNA5 and KCNA6 (By similarity). Isoform KvB1.2 has no effect on KCNA1, KCNA2 or KCNB1 (PubMed:7890032, PubMed:7890764). Enhances KCNB1 and KCNB2 channel activity (By similarity). Binds NADPH; this is required for efficient down-regulation of potassium channel activity (PubMed:17540341). Has NADPH-dependent aldoketoreductase activity (By similarity). Oxidation of the bound NADPH strongly decreases N-type inactivation of potassium channel activity (By similarity)

The "KCNAB1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNAB1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets